US EditionPerspectives of People with HCV Lived Experience and Healthcare Providers on Potential Long-Acting Therapies – hepCoalition
Summary by hepCoalition
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Perspectives of People with HCV Lived Experience and Healthcare Providers on Potential Long-Acting Therapies – hepCoalition
TAG releases an advocacy brief discussing findings from two surveys conducted among end users and healthcare providers/policy makers to understand their perspectives on potential long-acting therapies for HCV cure. LAT CAB (2021-present) / Long-acting technologies, Low- and middle-income countries
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium